Ingevity partners with Ultrapolymers Group for European sales of Capa® caprolactone Bioplastics

Rhea-AI Summary

Ingevity (NYSE:NGVT) has partnered with Ultrapolymers Group to expand the distribution of its Capa® caprolactone bioplastics in Europe. This strategic alliance aims to leverage Ultrapolymers' extensive sales and technical expertise to boost sales. Steve Hulme, Senior Vice President of Advanced Polymer Technologies at Ingevity, highlighted that this partnership will allow Ingevity to serve European customers better. David Viehoff from Ultrapolymers expressed excitement about adding Ingevity's innovative and sustainable bioplastics to their product portfolio. Ingevity specializes in products that purify, protect, and enhance the environment, operating in three segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals. Headquartered in North Charleston, South Carolina, Ingevity operates in 31 countries and employs around 1,700 people.

Positive

• Ingevity's partnership with Ultrapolymers Group expands the distribution network for Capa® caprolactone bioplastics in Europe.
• Leveraging Ultrapolymers' extensive sales and technical expertise aims to maximize sales in the European market.
• This alliance aligns with Ingevity's strategic plan for growth in Europe and enhances customer service.

Negative

• None.

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- Ingevity Corporation (NYSE:NGVT) today announced the expansion of its Capa® caprolactone distribution network by establishing Ultrapolymers Group as its distributor for Capa Bioplastics in Europe. Ultrapolymers Group will leverage the company’s experienced sales and technical teams across Europe to maximize the sales of Ingevity’s Capa Bioplastics products.

“Adding a new distribution partner within Europe who is dedicated to our line of Capa biodegradable thermoplastics enables us to better serve our customers in the region,” said Ingevity senior vice president and president, Advanced Polymer Technologies, Steve Hulme. “Ultrapolymers’ network of compounders and converters, as well as their technical expertise and customer service, aligns with Ingevity’s strategic plan for growth in Europe.”

“We are excited to add Ingevity to our portfolio of suppliers for the thermoplastics market,” said David Viehoff, management team at Ultrapolymers Group. “Ingevity’s portfolio of Capa caprolactone bioplastics aligns with our goal of offering the most advanced, innovative and sustainable materials to our customers.”

Ingevity: Purify, Protect, Enhance

Ingevity provides products and technologies that purify, protect and enhance the world around us. Through a team of talented and experienced people, we develop, manufacture and bring to market solutions that help customers solve complex problems and make the world more sustainable. We operate in three reporting segments: Performance Materials, which includes activated carbon; Advanced Polymer Technologies, which includes caprolactone polymers; and Performance Chemicals, which includes specialty chemicals and road technologies. Our products are used in a variety of demanding applications, including adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, lubricants, pavement markings, oil exploration and production and automotive components. Headquartered in North Charleston, South Carolina, Ingevity operates from 31 countries around the world and employs approximately 1,700 people. The company’s common stock is traded on the New York Stock Exchange (NYSE:NGVT). For more information, visit ingevity.com.

Ultrapolymers Group

Ultrapolymers Group is one of the leading pan-European distributors with over 20 years of experience in the industry. The company’s product portfolio is designed to meet customers’ needs across a wide range of industries, including automotive, aerospace, electrical, electronics, healthcare, packaging and consumer goods, with technical expertise and value-added services. As the company looks toward the future, it remains committed to sustainable and responsible business practices delivering solutions that empower businesses to thrive. Find out more information at www.ultrapolymers.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240709368624/en/

Caroline Monahan

843-740-2068

caroline.monahan@ingevity.com

Investors:

John E. Nypaver, Jr.

843-740-2002

investors@ingevity.com

Source: Ingevity Corporation

FAQ

What is the significance of Ingevity's partnership with Ultrapolymers for NGVT?

The partnership aims to expand the distribution of Ingevity's Capa® caprolactone bioplastics in Europe, leveraging Ultrapolymers' extensive sales and technical expertise to boost sales.

How will the partnership with Ultrapolymers affect Ingevity's sales of Capa bioplastics?

The partnership is expected to maximize sales of Ingevity's Capa® caprolactone bioplastics in Europe by using Ultrapolymers' experienced sales and technical teams.

What strategic advantage does Ingevity gain from the Ultrapolymers partnership?

Ingevity gains enhanced customer service and a broader distribution network in Europe, aligning with its strategic growth plan.

What are the operational segments of Ingevity (NGVT)?

Ingevity operates in three segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals.

How many countries does Ingevity operate in?

Ingevity operates in 31 countries around the world.